PJP INVESCO EXCHANGE TRADED FD T
FollowPHARMACEUTICALS (fund)
Filings received so far for Q3 2026: 6 13F filers report a position in PJP shares at 2026-09-30. The quarter is not complete: its 13F deadline is 2026-11-14, and the counts grow as filings arrive.
13D and 13G filers
No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.
Insider trades
No Form 4 transaction on this security in the data.
13F holders, Q3 2026
Filers in the available 13F reports with a share position at 2026-09-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.
| Holder | Shares | Value | % of portfolio | Change | Source |
|---|---|---|---|---|---|
| GILPIN WEALTH MANAGEMENT, LLC | 6,514 | $803K | 0.54% | -204 | 13F-HRTimeline |
| Sound Income Strategies, LLC | 1,940 | $235K | 0.01% | new | 13F-HRTimeline |
| Farther Finance Advisors, LLC | 379 | $46.7K | <0.01% | +3 | 13F-HRTimeline |
| GAMMA Investing LLC | 241 | $29.7K | <0.01% | 0 | 13F-HRTimeline |
| ARMSTRONG ADVISORY GROUP, INC | 60 | $7.4K | <0.01% | 0 | 13F-HRTimeline |
| Bank & Trust Co | 60 | $7.4K | <0.01% | 0 | 13F-HRTimeline |